Beta UBK International Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Beta UBK International General Information
Description
Manufacturer of generic oncology medicines serving Central Asia, MENA, South Africa and Latin America. The company offers medicines for breast cancer, lung cancer, head and neck cancer, colorectal cancer, ovarian cancer, gastric cancer, brain tumor, testicular cancer, renal cancer, prostate cancer, leukemia, lymphoma, myeloma and supportive cancer care.
Contact Information
Website
www.betaubk.uzCorporate Office
- Syrdarya Street, 8
- Tashkent region
- Bekobod, 110502
- Uzbekistan
Corporate Office
- Syrdarya Street, 8
- Tashkent region
- Bekobod, 110502
- Uzbekistan
Beta UBK International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beta UBK International FAQs
-
When was Beta UBK International founded?
Beta UBK International was founded in 2018.
-
Where is Beta UBK International headquartered?
Beta UBK International is headquartered in Bekobod, Uzbekistan.
-
What industry is Beta UBK International in?
Beta UBK International’s primary industry is Pharmaceuticals.
-
Is Beta UBK International a private or public company?
Beta UBK International is a Private company.
-
What is Beta UBK International’s current revenue?
The current revenue for Beta UBK International is .
-
When was Beta UBK International acquired?
Beta UBK International was acquired on 01-Oct-2018.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process